ABSTRACT COVID-19 is caused by SARS-CoV-2. Although pulmonary manifestations have
been identified as the major symptoms, several hematological abnormalities have also been …

COVID-19, a respiratory viral infection, has affected 388 million individuals worldwide as of
the February 4, 2022. In this review, we have outlined the important liver manifestations of …

Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel
strain that causes acute respiratory illnesses known as coronavirus disease 2019 (COVID …

Abstract Emerging from Wuhan, China, SARS-CoV-2 is the new global threat that killed
millions of people, and many are still suffering. This pandemic has not only affected people …

We investigated Favipiravir (FPV) efficacy in mild cases of COVID-19 without pneumonia
and its effects towards viral clearance, clinical condition, and risk of COVID-19 pneumonia …

The pandemic outbreak of SARS-CoV-2, with millions of infected patients worldwide, has
severely challenged all aspects of public health. In this regard, early and rapid detection of …

Background The role of favipiravir in preventing disease progression in coronavirus disease
2019 (COVID-19) remains uncertain. We aimed to determine its effect in preventing disease …

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has affected over 220 million individuals worldwide, and has …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2, has currently affected> 220 million individuals worldwide. The …

The 2019 novel coronavirus (2019-nCoV), commonly known as severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) or coronavirus disease 2019 (COVID-19), was first …